Biohit Oyj
OMXH:BIOBV
Intrinsic Value
The intrinsic value of one BIOBV stock under the Base Case scenario is 3.86 EUR. Compared to the current market price of 2.57 EUR, Biohit Oyj is Undervalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Biohit Oyj
Fundamental Analysis

Revenue & Expenses Breakdown
Biohit Oyj
Balance Sheet Decomposition
Biohit Oyj
Current Assets | 11m |
Cash & Short-Term Investments | 6.7m |
Receivables | 3.2m |
Other Current Assets | 1.1m |
Non-Current Assets | 4.6m |
Long-Term Investments | 139k |
PP&E | 702k |
Intangibles | 492k |
Other Non-Current Assets | 3.2m |
Free Cash Flow Analysis
Biohit Oyj
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Biohit Oyj
Revenue
|
14.3m
EUR
|
Cost of Revenue
|
-4.9m
EUR
|
Gross Profit
|
9.3m
EUR
|
Operating Expenses
|
-6.8m
EUR
|
Operating Income
|
2.6m
EUR
|
Other Expenses
|
11k
EUR
|
Net Income
|
2.6m
EUR
|
BIOBV Profitability Score
Profitability Due Diligence
Biohit Oyj's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
Score
Biohit Oyj's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
BIOBV Solvency Score
Solvency Due Diligence
Biohit Oyj's solvency score is 98/100. The higher the solvency score, the more solvent the company is.
Score
Biohit Oyj's solvency score is 98/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIOBV Price Targets Summary
Biohit Oyj
According to Wall Street analysts, the average 1-year price target for BIOBV is 3.26 EUR with a low forecast of 3.23 EUR and a high forecast of 3.36 EUR.
Dividends
Current shareholder yield for BIOBV is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one BIOBV stock under the Base Case scenario is 3.86 EUR.
Compared to the current market price of 2.57 EUR, Biohit Oyj is Undervalued by 33%.